Advent Life Sciences LLP 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-20 8:13 pm Purchase | 2024-08-20 | 13D | Eloxx Pharmaceuticals, Inc. ELOX | Advent Life Sciences LLP | 124,972 3.980% | 61,665 (+97.41%) | Filing |
| 2021-04-13 2:05 pm Purchase | 2021-04-01 | 13D | Eloxx Pharmaceuticals, Inc. ELOX | Advent Life Sciences LLP | 63,307 6.300% | 63,307 (New Position) | Filing |